Article Details

Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis

Retrieved on: 2022-11-22 13:58:29

Tags for this article:

Click the tags to see associated articles and topics

Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis. View article details on HISWAI: https://en.prnasia.com/releases/apac/triastek-receives-fda-ind-clearance-for-3d-printed-medicine-for-the-treatment-of-ulcerative-colitis-384559.shtml

Excerpt

NANJING, China, Nov. 21, 2022 /PRNewswire/ -- Triastek, Inc. ("Triastek") a global healthcare company pioneering 3D printing of pharmaceuticals ...

Article found on: en.prnasia.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up